Clinical Trial Update: Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Viralym-B, BK virus-specific T lymphocytes, for BK virus infection was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection

Drugs mentioned

• Viralym-B (BK virus-specific T lymphocytes)

Snippet

Sponsor: AlloVir | Conditions: BK Virus Infection | Phase 1 | Status: WITHDRAWN